Aclaris Therapeutics, Inc. - Common Stock (NQ:ACRS)

4.390 -0.020 (-0.45%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aclaris Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January ↗

March 06, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 33,471.14 while the NASDAQ rose...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 06, 2023

Via Benzinga

Aclaris Therapeutics's Return On Capital Employed Insights ↗

February 27, 2023

Via Benzinga

Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal ↗

December 04, 2022

Full-Life Technologies, a Brussels-Shanghai radiotherapeutics company, will acquire Focus-X Therapeutics for up to $245 million. Using its proprietary peptide engineering technology, Focus-X has built...

Via Talk Markets

10 Best Stocks to Buy Now in December ↗

December 01, 2022

These beaten-down stocks have significant upside.

Via The Motley Fool

Looking Into Aclaris Therapeutics Return On Capital Employed ↗

August 09, 2022

Via Benzinga

Recap: Aclaris Therapeutics Q1 Earnings ↗

May 10, 2022

Aclaris Therapeutics (NASDAQ:ACRS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Looking Into Aclaris Therapeutics's Return On Capital Employed ↗

December 05, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗

December 01, 2022

Via Benzinga

Aclaris Therapeutics: Q2 Earnings Insights ↗

August 03, 2022

Aclaris Therapeutics (NASDAQ:ACRS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Aclaris Therapeutics's Return On Capital Employed Insights ↗

June 08, 2022

According to data from Benzinga Pro, during Q1, Aclaris Therapeutics's (NASDAQ:ACRS) reported sales totaled $1.45 million. Despite a 17.61% increase in earnings, the company posted a loss of $18.79...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022 ↗

October 06, 2022

Upgrades

Via Benzinga

Airbnb And 3 Other Stocks Insiders Are Selling ↗

April 26, 2022

Although gold futures traded higher this morning on Tuesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s...

Via Benzinga

50 Biggest Movers From Yesterday ↗

January 13, 2022

Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises 50 Points; Jefferies Shares Drop ↗

January 12, 2022

Toward the end of trading Wednesday, the Dow traded up 0.05% to 36,269.24 while the NASDAQ rose 0.35% to 15,205.90. The S&P also rose, gaining, 0.26% to 4,725.52. The U.S...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 12, 2022

Gainers Immuron (NASDAQ:IMRN) shares rose 36.6% to $3.58 during Wednesday's regular session. Trading volume for this security as of 12:32 EST is 35.0 million, which is...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2%; Philips Shares Plummet ↗

January 12, 2022

Midway through trading Wednesday, the Dow traded up 0.26% to 36,346.85 while the NASDAQ rose 0.77% to 15,270.07. The S&P also rose, gaining, 0.57% to 4,739.98. The U.S. has...

Via Benzinga

28 Stocks Moving In Wednesday's Mid-Day Session ↗

January 12, 2022

Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing...

Via Benzinga

The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award ↗

January 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug Biogen...

Via Benzinga

Looking Into Aclaris Therapeutics's Return On Capital Employed ↗

November 02, 2021

Benzinga Pro data, Aclaris Therapeutics (NASDAQ:ACRS) reported Q3 sales of $1.66 million. Earnings fell to a loss of $20.30 million, resulting in a 12.71% decrease from last...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 16, 2021

Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Looking into Aclaris Therapeutics's Return on Capital Employed ↗

August 27, 2021

After pulling data from Benzinga Pro it seems like during Q2, Aclaris Therapeutics's (NASDAQ:ACRS) reported sales totaled $1.82 million. Despite a 36.89% in earnings, the company...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 23, 2021

Gainers Cara Therapeutics (NASDAQ:CARA) ...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 10, 2021

Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 09, 2021

Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is...

Via Benzinga

The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US ↗

June 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc...

Via Benzinga

75 Biggest Movers From Yesterday ↗

June 09, 2021

Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.